We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$10.6B
AUM Growth
+$1.17B
Cap. Flow
+$3.01B
Cap. Flow %
28.27%
Top 10 Hldgs %
22.3%
Holding
850
New
52
Increased
273
Reduced
342
Closed
48

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$96.9M
2
MRK icon
Merck
MRK
+$73.5M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.1M
4
ILMN icon
Illumina
ILMN
+$40.4M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$57.2M
2
IMMU
Immunomedics Inc
IMMU
+$51.7M
3
KMB icon
Kimberly-Clark
KMB
+$28.5M
4
BPMC
Blueprint Medicines
BPMC
+$26.5M
5
ANET icon
Arista Networks
ANET
+$22.7M

Sector Composition

Rank Sector Weight
1 Healthcare 35.77%
2 Technology 20.35%
3 Consumer Discretionary 9.49%
4 Communication Services 7.69%
5 Financials 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VZ icon
76
Verizon
VZ
$201B
$32.6M 0.31%
548,404
-35,188
-6% -$2.04M
ADSW
77
DELISTED
Advanced Disposal Services Inc
ADSW
$31.7M 0.3%
1,047,755
– –
ANSS
78
DELISTED
Ansys
ANSS
$31.1M 0.29%
95,153
-7,555
-7% -$2.37M
EA icon
79
Electronic Arts
EA
$52.4B
$30.7M 0.29%
235,538
+30,687
+15% +$4.18M
EQIX icon
80
Equinix
EQIX
$102B
$30.6M 0.29%
40,248
+11,702
+41% +$8.85M
TXN icon
81
Texas Instruments
TXN
$253B
$30.5M 0.29%
213,656
-4,920
-2% -$669K
EXEL icon
82
Exelixis
EXEL
$14.2B
$30M 0.28%
1,225,251
+833,965
+213% +$19.5M
PLD icon
83
Prologis
PLD
$137B
$29.6M 0.28%
294,292
+50,383
+21% +$5.05M
ISRG icon
84
Intuitive Surgical
ISRG
$130B
$29.1M 0.27%
123,246
+9,084
+8% +$2.04M
BALL icon
85
Ball Corp
BALL
$17.8B
$29.1M 0.27%
349,568
+77,807
+29% +$5.99M
ZYME icon
86
Zymeworks
ZYME
$1.66B
$29M 0.27%
622,060
+277,576
+81% +$9.53M
INCY icon
87
Incyte
INCY
$26B
$29M 0.27%
322,692
+2,126
+0.7% +$205K
ATVI
88
DELISTED
Activision Blizzard
ATVI
$28.7M 0.27%
354,611
-8,412
-2% -$682K
VAR
89
DELISTED
Varian Medical Systems, Inc.
VAR
$28.4M 0.27%
165,279
-45,668
-22% -$7.18M
XNCR icon
90
Xencor
XNCR
$1.48B
$28.4M 0.27%
731,687
+268,595
+58% +$9.33M
BMRN icon
91
BioMarin Pharmaceuticals
BMRN
$12B
$28M 0.26%
367,819
-1,821
-0.5% -$184K
VIPS icon
92
Vipshop
VIPS
$7.13B
$27.8M 0.26%
1,776,558
+62,558
+4% +$1.23M
BBY icon
93
Best Buy
BBY
$18.9B
$27.7M 0.26%
248,715
-8,113
-3% -$830K
ARNA
94
DELISTED
Arena Pharmaceuticals Inc
ARNA
$27.6M 0.26%
369,556
-84,519
-19% -$5.64M
HALO icon
95
Halozyme
HALO
$9.9B
$27.5M 0.26%
1,046,472
+49,594
+5% +$1.38M
T icon
96
AT&T
T
$169B
$27.4M 0.26%
1,274,563
-25,872
-2% -$578K
TECH icon
97
Bio-Techne
TECH
$11.2B
$27.3M 0.26%
440,440
-4,740
-1% -$308K
MRNA icon
98
CALL
Moderna
MRNA
$22.1B
$27.1M 0.25%
+38,214,700
New +$2.66B
KEYS icon
99
Keysight
KEYS
$52.2B
$27M 0.25%
273,712
+174,406
+176% +$17.1M
OLED icon
100
Universal Display
OLED
$3.85B
$26.7M 0.25%
147,783
+2,267
+2% +$387K
2 3
4
5 6

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2020 Portfolio in Review

As of Q3 2020, Candriam SCA held 850 positions worth $10.6B, up 12% from $9.47B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $3.01B of net new capital in Q3 2020, opening 52 new positions and adding to 273 existing holdings. Its largest new stake was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $57.2M trimmed.

  • Candriam SCA's largest Q3 2020 buy was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.
  • Candriam SCA added most to Amgen in Q3 2020, an estimated $96.9M increase.
  • Candriam SCA's biggest Q3 2020 reduction was Apple, cutting an estimated $57.2M.
  • Candriam SCA fully exited G1 Therapeutics, Inc. Common Stock in Q3 2020, selling an estimated $21.1M.
  • Candriam SCA's ten largest holdings make up 22% of its $10.6B portfolio in Q3 2020.
  • Candriam SCA opened 52 new positions and closed 48 in Q3 2020.
  • Candriam SCA's portfolio value rose 12% quarter-over-quarter to $10.6B.

Based on Candriam SCA's 13F filing for Q3 2020, filed 19 Oct 2020.